Related Experiment Video
Updated: Feb 1, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
A new therapy targeting HER2-positive cancers, ZW25, shows promise in early trials. This novel anti-HER2 drug demonstrated a 41% response rate with manageable side effects in patients with various HER2-positive tumors.
Area of Science:
- Oncology
- Pharmacology
Background:
- HER2-positive cancers represent a significant area of unmet medical need.
- Targeting the HER2 receptor is a validated therapeutic strategy in several cancer types.
Discussion:
- The novel anti-HER2 therapy ZW25 was evaluated in a phase I clinical trial.
- The study population primarily included patients with gastroesophageal and colorectal cancers.
Key Insights:
- ZW25 demonstrated an objective response rate of 41% in patients with HER2-positive cancers.
- The therapy was generally well-tolerated, with predominantly mild side effects observed.
Outlook:
- Further investigation of ZW25 in larger trials is warranted.
- ZW25 may offer a new treatment option for patients with refractory or advanced HER2-positive malignancies.
More Related Videos
08:05A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
Published on: June 8, 2018
10:21Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation
Published on: December 25, 2017
Related Concept Videos
Position-effect Variegation
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Position and Displacement
Serial Position Effect
Framing Effects
Position Vectors
For instance, we want to locate a point P(x, y, z) relative to the origin of coordinates O. In that case, we can define a position...